Compass Therapeutics (CMPX) Tax Provisions (2019 - 2021)

Compass Therapeutics has disclosed Tax Provisions across 3 years of filings, most recently posting -$13000.0 for Q4 2021.

• Tax Provisions for Q4 2021 came in at -$13000.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2022 was -$13000.0 (down 181.25% YoY), and the FY2020 annual result was $32000.0, down 64.84% from the prior year.
• Tax Provisions came in at -$13000.0 for Q4 2021 at Compass Therapeutics, down from $16000.0 in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $26000.0 in Q2 2019 to a low of -$13000.0 in Q4 2021.
• The 3-year median for Tax Provisions is $16000.0 (2020), against an average of $14200.0.
• Peak annual rise in Tax Provisions reached 38.46% in 2020, while the deepest fall reached 38.46% in 2020.
• Compass Therapeutics' Tax Provisions stood at $26000.0 in 2019, then slumped by 38.46% to $16000.0 in 2020, then slumped by 181.25% to -$13000.0 in 2021.
• The last three Tax Provisions figures came in at -$13000.0 (Q4 2021), $16000.0 (Q2 2020), and $16000.0 (Q1 2020), per Business Quant data.